Objectives: This study examined the effect of aspirin on the risk of embolic events in infective
endocarditis (IE). Background: Embolism is a major complication of IE, and studies in animal …

Background. In a recent clinical trial, aspirin therapy was initiated∼ 34 days after the onset
of symptoms but did not reduce the risk of embolism in patients with endocarditis. However …

Background. Embolism is a dreaded complication of infective endocarditis (IE). Currently,
antimicrobial therapy is the only medical intervention proven to decrease the risk of …

Objectives: This study was designed to assess the risk of systemic embolization in patients
with left-sided infective endocarditis, once adequate antibiotic treatment had been initiated …

ABSTRACT A retrospective study was undertaken to analyse the risk factors for systemic
emboli in infective endocarditis. Patients (n= 80; 70% males; mean age 65 years; range 20 …

BACKGROUND: Infective endocarditis often is complicated by embolic events after hospital
admission. Identifying patients at higher risk may improve the disease outcome. This study …

BACKGROUND: Embolic events to the central nervous system are a major cause of
morbidity and mortality in patients with infective endocarditis (IE). The appropriate role of …

Objective: To determine whether vegetations visualized on two-dimensional
echocardiography are an independent risk factor for the development of subsequent emboli …

To quantitate embolic risk we studied a retrospective series of 61 patients with strictly
defined bacterial endocarditis. Eighteen patients had neurological complications attributable …

Aims In infective endocarditis, the true incidence of embolic events and metastatic infections
remains unknown probably because a large number of events are asymptomatic. The …